Geneva, June 8 -- International Clinical Trials Registry received information related to the study (TCTR20260530009) titled 'Continuous versus extended infusion of meropenem in pediatric sepsis' on May 30.
Study Type: Interventional
Study Design:
Randomized
Primary Sponsor: Faculty of Pharmacy Universitas Indonesia
Condition:
Sepsis in children
Pediatric sepsis, sepsis, septic shock, meropenem, beta-lactam antibiotics, continuous infusion, extended infusion, pediatric intensive care unit, randomized controlled trial
Pediatric sepsis, sepsis, septic shock, meropenem, beta-lactam antibiotics, continuous infusion, extended infusion, pediatric intensive care unit, randomized controlled trial
Intervention:
Meropenem 40 mg/kg/dose (max...